Global Diabetic Therapeutic Market to grow at a CAGR of 7.55% during the period 2017 - 2021; Finds New Report

Report forecast the global diabetic therapeutic market to grow at a CAGR of 7.55% during the period 2017-2021.

The global diabetic therapeutic market is growing at a high pace owing to the increase in the prevalence of diabetes globally. The top countries with high prevalence of diabetes are China, India, the US, Brazil, Russia, Mexico, Indonesia, Egypt, Japan, and Bangladesh. It is estimated that more than 1.5 million deaths occur due to diabetes worldwide each year.

The report covers the present scenario and the growth prospects of the global diabetic therapeutic market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of branded drugs, generics, and biosimilars used for the treatment of diabetes. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period..

The market is divided into the following segments based on geography:

• Americas
• APAC
• EMEA

According to the report, one of the major drivers for this market is change in patient preference. Earlier days, the treatment for diabetes was more popular in hospitals where an endocrinologist or a dietician guided the individuals in type 1 diabetes management. Though there were fruitful results achieved, there were some issues like long waiting times leading to crowding, limited visiting slots, high consultation fees, and non-availability of devices stock have made people to look for alternatives. Due to these reasons, the individuals had to revisit the hospitals repeatedly to get the check-up done. This looked favorable from the view of hospitals as they had high demand.

Further, the report states that one of the major factors hindering the growth of this market is complex storage conditions and distribution policies for insulin. Besides the restricted affordability and accessibility of insulin-based disease management, insulin treatment also suffers from poor storage and distribution policies. Inadequate distribution policies and lack of a centralized supply chain lead to intra-country variability in pricing. A heavy tax on insulin delivery devices such as syringes also hinders effective disease management despite insulin availability.

Global Diabetic Therapeutic Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global diabetic therapeutic market: AstraZeneca, Eli Lilly, Merck, Novo Nordisk, and Sanofi.

Other Prominent Vendors in the market are: AbbVie, Actelion Pharmaceuticals, Adocia, Aegerion Pharmaceuticals, Akros Pharma, Alnylam Pharmaceuticals, Amarin, Amgen, Amicus Therapeutics, Arbutus Biopharma, Arena Pharmaceuticals, Astellas Pharma, Atheronova, Aurobindo Pharma, Baxalta, Belrose Pharma, BHV Pharma, Biocon, Biodel, BioMarin, Bionaturis, Biosidus, Biospherics, Boehringer Ingelheim, Bristol-Myers Squibb, Catabasis Pharmaceuticals, Cerenis Therapeutics, Chipscreen Biosciences, Cipla, CJ HealthCare, CKD Bio, Concord Biotech, ConjuChem, CureDM, CymaBay Therapeutics, Daewoong, Daiichi Sankyo, Dance Biopharm, DiaMedica, Diamyd Therapeutics, Diasome Pharmaceuticals, DiaVacs, Dong-A ST, Eisai, Elcelyx Therapeutics, Esperion Therapeutics, Exsulin, F. Hoffmann-La Roche, Gan & Lee Pharmaceuticals, Generex Biotechnology, Genfit, GlaxoSmithKline, HanAll BioPharma, Hanmi Pharmaceutical, Hua Medicine, Iltoo Pharma, Intarcia Therapeutics, InteKrin Therapeutics, Intrexon, Ionis Pharmaceuticals, Islet Sciences, ISU Abxis, Janssen Pharmaceuticals, Japan Tobacco, JCR Pharmaceuticals, JW Pharmaceuticals, Kadmon Pharmaceuticals, Kamada, KinDex Pharmaceuticals, Kissei, Kotobuki, Kowa Company, Laboratoires SMB, Lexicon Pharmaceuticals, Ligand Pharmaceuticals, Living Cell Technologies, Livzon, LIXTE Biotechnology, Lupin, MacroGenics, Madrigal Pharmaceuticals, MannKind Corporation, MedImmune, Melior Pharmaceuticals, Merrion Pharmaceuticals, Merz Pharmaceuticals, Metabolic Solutions Development, Mitsubishi Tanabe Pharma, Mylan, Neothetics, Neuraltus Pharmaceuticals, NGM Biopharmaceuticals, Norgine, Novartis, NuSirt Biopharma, Oramed, Orexigen Therapeutics, Osiris Therapeutics, Peptron, Perle Biosciences, Pfizer, PhaseBio Pharmaceuticals, Poxel, Protalix BioTherapeutics, Raptor, Recordati, Regeneron Pharmaceuticals, REGENX BioSciences, REGiMMUNE, Rhythm Pharmaceuticals, Saniona, Santaris Pharma, Sanwa Kagaku Kenkyusho, Serometrix, Shionogi, Shire, Sigma-Tau, Sirona Biochem, Strongbridge Biopharma, Sun Pharma, Takeda Pharmaceuticals, Teva, Thera Technologies, Theracos, Toleranzia, Tolerion, Torrent Pharmaceuticals, Transition Therapeutics, UCB, Utrecht Holdings, VeroScience, Vivus, vTv Therapeutics, XBiotech, Xeris Pharmaceuticals, XOMA, Zafgen, and Zydus Cadila

Market driver

• Change in patient preference
• For a full, detailed list, view our report

Market challenge

• Complex storage conditions and distribution policies for insulin
• For a full, detailed list, view our report

Market trend

• Focus on oral insulin therapies
• For a full, detailed list, view our report

Key questions answered in this report

• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 167 pages and 102 Exhibits “Global Diabetic Therapeutic Market 2017 - 2021” report covers Executive summary, Scope of the report, Market research methodology, Introduction, Market landscape, Disease overview: Diabetes, Pipeline portfolio, Overview of marketed products, Market segmentation by type of disease, Market segmentation by drug class, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For more information Visit at: http://mrr.cm/UoX

Related Reports;

Global Short Peripheral Intravenous Catheter Market 2017-2021 - Visit at - http://mrr.cm/UoB

Global Female Condoms Market 2017-2021 - Visit at - http://mrr.cm/Uo2